Showing results (211-220 of 244) with videos related to

Sort By:
Pageof 25
Nucleic Acids Research|July 16, 2020
PARP1 catalytic variants reveal branching and chain length-specific functions of poly(ADP-ribose) in cellular physiology and stress responseLisa Aberle, Annika Krüger, Julia M Reber, et al.
International Journal of Cancer|September 19, 2015
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancersChristoph Burdelski, Sandra Kleinhans, Martina Kluth, et al.
Nature Chemistry|November 23, 2023
Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learningDavid F Nippa, Kenneth Atz, Remo Hohler, et al.
Histopathology|July 17, 2013
MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancerAlexander Quaas, Ahmad Soliaman Bahar, Katharina von Loga, et al.
British Journal of Haematology|February 2, 2013
Cytogenetics of extramedullary manifestations in multiple myelomaLisa Billecke, Eva M Murga Penas, Annette M May, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
Human Pathology|October 7, 2008
Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel diseaseAndreas Marx, Timo Wandrey, Philipp Simon, et al.
Molecular Membrane Biology|February 15, 2011
A class of mild surfactants that keep integral membrane proteins water-soluble for functional studies and crystallizationJens Hovers, Meike Potschies, Ange Polidori, et al.
Scientific Reports|June 4, 2020
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancersAndreas Marx, Aljoscha Schumann, Doris Höflmayer, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2020
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancersKatharina Möller, Anna Lena Wecker, Doris Höflmayer, et al.
Pageof 25